The medium and long-term debt of pharmaceutical firm Unimed listed on Tunisia stock exchange grew by 448% year to year in S1, 2019 to reach TND20.8 million.
The firm explains that during the period under review, it borrowed TND4.8 million from banks for its expansion project.
According to Moroccan media citing Charfeddine Ridha (photo), UNIMED’s managing director, an TND80 million-investment plan is announced for the expansion of the firms’ laboratories.
Despite the growth of its debt, Unimed’s turnover rose by 124% year on year to reach TND31.1 million thanks to its sales on local and foreign markets that quarter.
Chamberline MOKO
Omer-Decugis & Cie acquired 100% of Côte d’Ivoire–based Vergers du Bandama. Vergers du Band...
Eritrea faces some of the Horn of Africa’s deepest infrastructure and climate-resilience gaps, lim...
Huaxin's $100M Balaka plant localizes clinker production, saving Malawi $50M yearly in f...
Nigeria seeks Boeing-Cranfield partnership to build national aircraft MRO centre Project aims t...
BCEAO keeps key lending rate at 3.25% and marginal rate at 5.25%. UEMOA growth reaches 6.6%...
Egypt launches tender for private operator at Hurghada International Airport Move part of plan to upgrade 11 airports, double tourist numbers by 2030...
Tanzania signs deal to revive Bagamoyo port with Africa Global Logistics Project includes 3 berths at Bagamoyo, 2 more at Dar es Salaam port...
African ministers adopt Algiers Declaration on regulating global digital platforms Framework seeks fairer terms with OTTs, stronger data and AI...
Ghana’s Q3 2025 GDP grew 5.5%, led by agriculture and services Growth slowed due to hydrocarbons slump and weak industrial performance...
Cameroon’s REPACI film festival returns Dec. 11-13 with 135 short films Events include screenings, masterclasses, panels on social cinema and...
Cidade Velha, formerly known as Ribeira Grande, holds a distinctive place in the history of Cape Verde and, more broadly, in the history of the Atlantic...